MedPath

CardioRoot Post-Marketing Surveillance Registry

Completed
Conditions
Cardiovascular Surgical Procedure
Interventions
Device: CardioRoot graft
Registration Number
NCT01609270
Lead Sponsor
Maquet Cardiovascular
Brief Summary

Post-marketing surveillance registry of the CardioRoot graft.

Detailed Description

Study objective is to monitor the performance and safety of CardioRoot vascular grafts implanted in a thoracic position. Patient survival rates will be monitored as well as immediate and long-term complications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • patients requiring a CardioRoot graft as per the CardioRoot Instructions for Use (IFU)
Exclusion Criteria
  • patients with contra-indications per CardioRoot IFU
  • patients requiring consecutive aortic surgery
  • patients with coronary artery disease
  • patients who require urgent or emergent surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CardioRootCardioRoot graftAll subjects receive the CardioRoot graft at baseline implant procedure.
Primary Outcome Measures
NameTimeMethod
Graft complications1 year

Complications will be assessed out to one year post implantation.

Secondary Outcome Measures
NameTimeMethod
Subject mortality rate30 days, 1 year

Subject mortality rate will be followed out to one year post implantation.

Trial Locations

Locations (6)

General University Hospital

🇨🇿

Prague, Czechia

University Hospital Motol

🇨🇿

Prague, Czechia

Centre Hospitalier Universitaire (CHU) de Bordeaux

🇫🇷

Bordeaux, France

University Hospital Olomouc

🇨🇿

Olomouc, Czechia

Ospedale Manzoni di Lecco

🇮🇹

Lecco, Italy

Ospedale Luigi Sacco

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath